High blood pressure pill cuts risk of Parkinson's disease

February 6, 2008

People taking a widely used group of drugs known as calcium channel blockers to treat high blood pressure also appear to be cutting their risk of Parkinson’s disease, according to a study published in the February 6, 2008, online issue of Neurology.

The study involved 7,374 men and women over age 40. Half of the group had Parkinson’s disease; the other half did not have Parkinson’s disease. Among both groups, nearly half used high blood pressure medications, such as calcium channel blockers, ACE inhibitors, AT II antagonists and beta blockers.

The study found people who were currently long-term users of calcium channel blockers to treat high blood pressure lowered their risk of Parkinson’s disease by 23 percent compared to people who didn’t take the drugs. There was no such effect among people taking ACE inhibitors, AT II antagonists and beta blockers.

“Long-term use of calcium channel blockers was associated with a reduced risk of developing Parkinson’s disease while no such association was seen for other high blood pressure medicines,” said study author Christoph R. Meier, PhD, MSc, with University Hospital Basel in Switzerland.

Meier says more research is needed to determine why calcium channel blockers appear to protect against Parkinson’s disease, whether this is indeed a causal association, and why the other high blood pressure medications do not offer a reduced risk.

Source: American Academy of Neurology


print this article email this article download pdf blog this article bookmark this article     Stumble it Digg this share on Facebook retweet share on Reddit add to delicious
Rate this story - 4.5 /5 (6 votes)


February 6, 2008 all stories

Comments: 0

4.5 /5 (6 votes)
  • Stumble this up

  • Digg this

  • share this

  • hide
  • Related Stories




  • hide
  • Relevant PhysicsForums posts

  • nesfatin
    created 9 hours ago
  • Obsessive Compulsive Disorder
    created Nov 20, 2009
  • West's zone 2 starling resistor respiratory physiology
    created Nov 18, 2009
  • 50-0-50 rule
    created Nov 18, 2009
  • More from Physics Forums - Medical Sciences

Other News

New cancer target for non-Hodgkin's lymphoma

Medicine & Health / Cancer

created 9 hours ago | popularity 5 / 5 (1) | comments 0

Physician-scientists from Weill Cornell Medical College have discovered a molecular mechanism that may prove to be a powerful target for the treatment of non-Hodgkin's lymphoma, a type of cancer that affects lymphocytes, ...


Surface bacteria maintain skin's healthy balance

Medicine & Health / Research

created 10 hours ago | popularity 5 / 5 (4) | comments 0

On the skin's surface, bacteria are abundant, diverse and constant, but inflammation is undesirable. Research at the University of California, San Diego School of Medicine now shows that the normal bacteria living on the ...


Gene mismatch influences success of bone marrow transplants

Medicine & Health / Genetics

created 9 hours ago | popularity 4 / 5 (1) | comments 0

A commonly inherited gene deletion can increase the likelihood of immune complications following bone marrow transplantation, an international team of researchers reports in the November 22 advance online issue of Nature Ge ...


New understanding about mechanism for cell death after stroke leads to possible therapy

Medicine & Health / Research

created 10 hours ago | popularity not rated yet | comments 0

Scientists at the Brain Research Centre, a partnership of the University of British Columbia Faculty of Medicine and Vancouver Coastal Health Research Institute, have uncovered new information about the mechanism by which ...


Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer

Medicine & Health / Cancer

created 10 hours ago | popularity not rated yet | comments 0

Agios Pharmaceuticals today announced that its scientists have established, for the first time, that the mutated IDH1 gene has a novel enzyme activity consistent with a cancer-causing gene, or oncogene. This breakthrough ...